News
Balaxi Pharmaceuticals consolidated net profit declines 95.42% in the September 2025 quarter
11-Nov-2025 | 16:36
Sales decline 27.40% to Rs 56.18 crore
Net profit of Balaxi Pharmaceuticals declined 95.42% to Rs 0.21 crore in the quarter ended September 2025 as against Rs 4.59 crore during the previous quarter ended September 2024. Sales declined 27.40% to Rs 56.18 crore in the quarter ended September 2025 as against Rs 77.38 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 56.18 | 77.38 | -27 |
| OPM % | 2.06 | 13.69 | - |
| PBDT | 1.86 | 6.03 | -69 |
| PBT | 1.38 | 5.56 | -75 |
| NP | 0.21 | 4.59 | -95 |
Powered by Capital Market - Live News